Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The FOXO1/KLOTHO pathway, often referred to as the Klotho-FOXO1 signaling axis, is a key molecular mechanism that integrates systemic metabolism with cellular stress resistance and longevity. Klotho is a transmembrane protein primarily expressed in the kidneys that acts as an aging suppressor; it can be shed into the circulation as a soluble hormone. In this pathway, Klotho inhibits the insulin and insulin-like growth factor-1 (IGF-1) signaling cascades, which typically activate the PI3K/AKT pathway. Because AKT normally phosphorylates and inactivates the transcription factor FOXO1 by sequestering it in the cytoplasm, Klotho-mediated inhibition of AKT allows FOXO1 to translocate into the nucleus. Once in the nucleus, FOXO1 drives the transcription of essential antioxidant enzymes, such as manganese superoxide dismutase (MnSOD), which neutralize reactive oxygen species and protect cells from oxidative damage. Disruption of the FOXO1/KLOTHO axis is closely linked to age-related pathologies, including chronic kidney disease, cardiovascular dysfunction, and neurodegeneration. In many disease states, Klotho levels decline, leading to increased oxidative stress and impaired FOXO1-mediated cellular protection. Therapeutic interventions aimed at this pathway include the use of recombinant Klotho protein or drugs like SGLT2 inhibitors and Vitamin D analogs that enhance endogenous Klotho expression. Such strategies are being explored to treat metabolic syndrome and slow the progression of chronic renal and vascular diseases.
Pharmacological activation of the pathway generally occurs by upregulating Klotho expression or activity, which inhibits the PI3K/AKT signaling axis. This inhibition prevents the phosphorylation-dependent nuclear export of FOXO1, allowing it to remain in the nucleus and activate the transcription of antioxidant, anti-apoptotic, and longevity-promoting genes.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Klotho-Forkhead box protein O1 signaling pathway (KL-FOXO1 pathway).